Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
Guilabert
A
A
Bosch
X
X
Julià
M
M
Iranzo
P
P
Mascaró
J M
JM
D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005141:Eyelid Diseases / Q000139:chemically induced; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012507:Sarcoidosis / Q000139:chemically induced*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b